COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.
Summary of new research into viral load with SARS-CoV-2.
HHS details state-level support for COVID-19 testing and monitoring, with the more than $19 billion to be allocated through the existing CDC ELC cooperative agreement.
While diagnostic testing for COVID-19 slowly shifts away from clinical laboratories, these changes can be beneficial.
Two key trends are explained as potential opportunities for clinical laboratories in the year ahead.
How SARS-CoV-2 (COVID-19) testing evolved from diagnostic testing only in clinical laboratories to three categories of primary diagnostic and secondary testing.
The scientific community starred in the development of several innovations designed to overcome the healthcare challenges brought on by the COVID-19 pandemic.
Summary of new research into viral load with SARS-CoV-2.
HHS details state-level support for COVID-19 testing and monitoring, with the more than $19 billion to be allocated through the existing CDC ELC cooperative agreement.
While diagnostic testing for COVID-19 slowly shifts away from clinical laboratories, these changes can be beneficial.
Two key trends are explained as potential opportunities for clinical laboratories in the year ahead.
How SARS-CoV-2 (COVID-19) testing evolved from diagnostic testing only in clinical laboratories to three categories of primary diagnostic and secondary testing.
The scientific community starred in the development of several innovations designed to overcome the healthcare challenges brought on by the COVID-19 pandemic.
